Psychiatric Symptoms in a Patient with Influenza A (H1N1) Treated with Oseltamivir (Tamiflu): A Case Report

Sang Won Jeon; Changsu Han

doi:10.9758/cpn.2015.13.2.209

Psychiatric Symptoms in a Patient with Influenza A (H1N1) Treated with Oseltamivir (Tamiflu): A Case Report

Sang Won Jeon, Changsu Han

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Abstract

Oseltamivir is the most common antiviral drug used to treat and prevent influenza. Epidemiological studies performed in Japan, the United States, and the United Kingdom indicate that oseltamivir may cause psychiatric symptoms; however, the underlying mechanism has not been elucidated. In South Korea, interest in oseltamivir has increased with the spread of the new influenza virus; however, no case report or investigation of psychiatric symptoms associated with the drug has been reported to date. Here, we report a case of a 22-year-old male who complained of mood swings, suicidal feelings, auditory hallucinations, memory deterioration, and insomnia after taking oseltamivir.

Original language	English
Pages (from-to)	209-211
Number of pages	3
Journal	Clinical Psychopharmacology and Neuroscience
Volume	13
Issue number	2
DOIs	https://doi.org/10.9758/cpn.2015.13.2.209
Publication status	Published - 2015 Aug 1
Externally published	Yes

Keywords

Human influenza
Oseltamivir
Psychiatric symptom
Side effect
Tamiflu

ASJC Scopus subject areas

Psychiatry and Mental health
Behavioral Neuroscience
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.9758/cpn.2015.13.2.209

Cite this

@article{66c3e423ed644e7a8a46098b5ccd26f5,

title = "Psychiatric Symptoms in a Patient with Influenza A (H1N1) Treated with Oseltamivir (Tamiflu): A Case Report",

abstract = "Oseltamivir is the most common antiviral drug used to treat and prevent influenza. Epidemiological studies performed in Japan, the United States, and the United Kingdom indicate that oseltamivir may cause psychiatric symptoms; however, the underlying mechanism has not been elucidated. In South Korea, interest in oseltamivir has increased with the spread of the new influenza virus; however, no case report or investigation of psychiatric symptoms associated with the drug has been reported to date. Here, we report a case of a 22-year-old male who complained of mood swings, suicidal feelings, auditory hallucinations, memory deterioration, and insomnia after taking oseltamivir.",

keywords = "Human influenza, Oseltamivir, Psychiatric symptom, Side effect, Tamiflu",

author = "Jeon, {Sang Won} and Changsu Han",

note = "Publisher Copyright: Copyright {\textcopyright} 2015, Korean College of Neuropsychopharmacology.",

year = "2015",

month = aug,

day = "1",

doi = "10.9758/cpn.2015.13.2.209",

language = "English",

volume = "13",

pages = "209--211",

journal = "Clinical Psychopharmacology and Neuroscience",

issn = "1738-1088",

publisher = "Korean College of Neuropsychopharmacology",

number = "2",

}

TY - JOUR

T1 - Psychiatric Symptoms in a Patient with Influenza A (H1N1) Treated with Oseltamivir (Tamiflu)

T2 - A Case Report

AU - Jeon, Sang Won

AU - Han, Changsu

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Oseltamivir is the most common antiviral drug used to treat and prevent influenza. Epidemiological studies performed in Japan, the United States, and the United Kingdom indicate that oseltamivir may cause psychiatric symptoms; however, the underlying mechanism has not been elucidated. In South Korea, interest in oseltamivir has increased with the spread of the new influenza virus; however, no case report or investigation of psychiatric symptoms associated with the drug has been reported to date. Here, we report a case of a 22-year-old male who complained of mood swings, suicidal feelings, auditory hallucinations, memory deterioration, and insomnia after taking oseltamivir.

AB - Oseltamivir is the most common antiviral drug used to treat and prevent influenza. Epidemiological studies performed in Japan, the United States, and the United Kingdom indicate that oseltamivir may cause psychiatric symptoms; however, the underlying mechanism has not been elucidated. In South Korea, interest in oseltamivir has increased with the spread of the new influenza virus; however, no case report or investigation of psychiatric symptoms associated with the drug has been reported to date. Here, we report a case of a 22-year-old male who complained of mood swings, suicidal feelings, auditory hallucinations, memory deterioration, and insomnia after taking oseltamivir.

KW - Human influenza

KW - Oseltamivir

KW - Psychiatric symptom

KW - Side effect

KW - Tamiflu

UR - http://www.scopus.com/inward/record.url?scp=84939492869&partnerID=8YFLogxK

U2 - 10.9758/cpn.2015.13.2.209

DO - 10.9758/cpn.2015.13.2.209

M3 - Article

AN - SCOPUS:84939492869

VL - 13

SP - 209

EP - 211

JO - Clinical Psychopharmacology and Neuroscience

JF - Clinical Psychopharmacology and Neuroscience

SN - 1738-1088

IS - 2

ER -

Psychiatric Symptoms in a Patient with Influenza A (H1N1) Treated with Oseltamivir (Tamiflu): A Case Report

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this